Myeloid Sarcoma of the Bladder in a Patient with Chronic myelomonocytic Leukaemia

Rebecca Smith, B. Mohamed, Jeremy C. Nettleton
{"title":"Myeloid Sarcoma of the Bladder in a Patient with Chronic myelomonocytic Leukaemia","authors":"Rebecca Smith, B. Mohamed, Jeremy C. Nettleton","doi":"10.22374/jeleu.v4i3.132","DOIUrl":null,"url":null,"abstract":"BackgroundMyeloid sarcoma is a rare extramedullary tumour of immature granulocytes, most commonly involving the skin, bone, lymph nodes, and soft tissue. It is usually associated with a diagnosis of relapsed or de novo acute myeloid leukaemia, acute lymphoblastic transformation of a myelodysplastic/myeloproliferative neoplasm, or can occur as isolated myeloid sarcoma.Case reportA 66-year-old female with a 7-year history of stable chronic myelomonocytic leukaemia presents with urgency, frequency, dysuria symptoms, and without new constitutional symptoms. She is found to have atypical, multifocal lesions on the right posterolateral wall of the bladder with associated hydronephrosis. Pathology reveals the diagnosis as myeloid sarcoma; surprisingly, bone marrow evaluation does not show evidence of acute leukaemic transformation.ConclusionsMyeloid sarcoma occurring in patients with chronic myelomonocytic leukaemia is extremely rare, and there are no cases reported in the English literature of these patients developing lesions in the bladder. The urological manifestations of an underlying haematological malignancy are best managed with a combination of systemic chemotherapy and allogeneic stem cell transplant, and in this case, the only surgical intervention required was ureteric stenting and tissue biopsy. Although rare, it is essential to consider alternative diagnoses when confronted with an atypical bladder tumour; failure to do so may result in patient harm by exposure to unnecessary intervention and delay to potentially curative treatment.","PeriodicalId":136362,"journal":{"name":"Journal of Endoluminal Endourology","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endoluminal Endourology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22374/jeleu.v4i3.132","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

BackgroundMyeloid sarcoma is a rare extramedullary tumour of immature granulocytes, most commonly involving the skin, bone, lymph nodes, and soft tissue. It is usually associated with a diagnosis of relapsed or de novo acute myeloid leukaemia, acute lymphoblastic transformation of a myelodysplastic/myeloproliferative neoplasm, or can occur as isolated myeloid sarcoma.Case reportA 66-year-old female with a 7-year history of stable chronic myelomonocytic leukaemia presents with urgency, frequency, dysuria symptoms, and without new constitutional symptoms. She is found to have atypical, multifocal lesions on the right posterolateral wall of the bladder with associated hydronephrosis. Pathology reveals the diagnosis as myeloid sarcoma; surprisingly, bone marrow evaluation does not show evidence of acute leukaemic transformation.ConclusionsMyeloid sarcoma occurring in patients with chronic myelomonocytic leukaemia is extremely rare, and there are no cases reported in the English literature of these patients developing lesions in the bladder. The urological manifestations of an underlying haematological malignancy are best managed with a combination of systemic chemotherapy and allogeneic stem cell transplant, and in this case, the only surgical intervention required was ureteric stenting and tissue biopsy. Although rare, it is essential to consider alternative diagnoses when confronted with an atypical bladder tumour; failure to do so may result in patient harm by exposure to unnecessary intervention and delay to potentially curative treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性髓细胞白血病患者膀胱髓样肉瘤
背景:髓系肉瘤是一种罕见的髓外肿瘤,由未成熟的粒细胞组成,最常累及皮肤、骨骼、淋巴结和软组织。它通常与复发或新发急性髓性白血病、骨髓增生异常/骨髓增生性肿瘤的急性淋巴细胞转化有关,也可以作为孤立的髓性肉瘤发生。病例报告:66岁女性,7年稳定慢性髓细胞白血病病史,出现尿急、尿频、排尿困难症状,无新的体质症状。她被发现有不典型的,膀胱右后外侧壁多灶性病变并伴有肾积水。病理诊断为髓系肉瘤;令人惊讶的是,骨髓评估没有显示急性白血病转化的证据。结论慢性髓细胞白血病患者发生髓样肉瘤极为罕见,英文文献未见此类患者膀胱病变的报道。潜在的血液恶性肿瘤的泌尿系统表现最好通过全身化疗和同种异体干细胞移植相结合来控制,在这种情况下,唯一需要的手术干预是输尿管支架置入和组织活检。虽然罕见,但当遇到非典型膀胱肿瘤时,必须考虑其他诊断;如果不这样做,可能会因暴露于不必要的干预和延迟潜在的治愈治疗而导致患者受到伤害。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Inverted Y Ureteral Duplication with Distal Obstructing Calculi in the Ectopic Ureter in the Prostatic Urethra Post-operative Events with Post-operative Day One Stent Removal after Percutaneous Nephrolithotomy Teflon Injections (STING) Mimicking Distal Ureteric Stones Proceedings of the Welsh Urological Society Annual Meeting The Role of the ClearPetra Suction Access Sheath and UROFINO Disposable Ureteroscope as an Alternative to PCNL/Conventional Flexible Ureteroscopy for a Large Renal Pelvis Stone
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1